Home ⟩ Insights

Insights

1701

1 min read • March 24, 2017

Option Alert: THC Apr 17.5 Puts Sweep: 3996 @ ASK $1.298: 3996 traded vs 0 OI: Earnings 5/1 After Close (est) $17.69 Ref

3 min read • March 21, 2017

Cronos Execs On Marijuana Legalization In Canada And How It Affects The Co: Market Could Be Ready To Go By 2019

1 min read • March 21, 2017

IGC Files Patent for Cannabis-based Therapy for Treatment of Eating Disorders

5 min read • March 20, 2017

Cronos Group Execs Discuss The Challenges Of Exporting Cannabis As An Insurance-Reimbursed Product

4 min read • March 19, 2017

Marijuana Stocks And Indices On A Downtrend: Who’s Taking The Heat And Why

7 min read • March 18, 2017

Cronos Group Execs Talk About Cannabis Co., Recent ‘Bought Deal’ And Expansion Plans

4 min read • March 17, 2017

Garbage Companies & The Marijuana Industry: Expert Warns About Overvalued Cannabis Stocks

3 min read • March 16, 2017

Why Education Could Be The Biggest Beneficiary Of Cannabis Legalization

5 min read • March 15, 2017

Getting Into The Business Of Medical Marijuana: An Interview With IGC CEO Ram Mukunda

4 min read • March 14, 2017

Trump, Sessions, Spicer And Medical Marijuana: Industry Insiders Discuss The Future Of Cannabis

7 min read • March 13, 2017

How To Pick The Right Marijuana Stocks

4 min read • March 10, 2017

Marijuana Stocks: How CEOs Can Navigate Market Volatility (And Survive Spicer And Sessions)

Latest Headlines

3 min read • April 30, 2026

Cannabis Earnings Show How Verano and SNDL Are Navigating Margin Pressure, Pricing, and Uneven Demand

3 min read • April 30, 2026

Medical Cannabis Operators Face New Federal Compliance Costs as Schedule III Shift Advances

2 min read • April 29, 2026

This Southern State Is Still an Untapped Cannabis Market As Lawmakers Revisit Medical Marijuana Policy

3 min read • April 29, 2026

Vext Science Cannabis Co. Boosts Cash Flow 256% YoY, Margins Grow in 2025 Ahead of Ohio Push

3 min read • April 29, 2026

New Lawsuit Claims CMS Medicare Cannabis Program Undermines FDA-Approved Drug Development

4 min read • April 28, 2026

Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck

3 min read • April 28, 2026

This Cannabis Giant Plans Nevada Registration, Here’s What Shareholders And Investors Need To Know

2 min read • April 28, 2026

TerrAscend Extends Cash Flow Streak To 15 Quarters As Growth Returns, Shares Pop

4 min read • April 27, 2026

DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know

4 min read • April 27, 2026

Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect

4 min read • April 27, 2026

EXCLUSIVE: Safe Harbor Launches First Cannabis‑Ready 401K Plan

min read • April 27, 2026

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.